- Home
- Publications
- Publication Search
- Publication Details
Title
Statins use and cancer: an update
Authors
Keywords
-
Journal
Future Oncology
Volume 14, Issue 15, Pages 1497-1509
Publisher
Future Medicine Ltd
Online
2018-05-03
DOI
10.2217/fon-2017-0543
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
- (2018) Louise Emilsson et al. JAMA Oncology
- Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer
- (2017) Signe Benzon Larsen et al. JOURNAL OF CLINICAL ONCOLOGY
- Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study
- (2017) Ming-Szu Hung et al. PLoS One
- Effect of statins as a secondary chemopreventive agent among individuals with non–muscle-invasive bladder cancer: A population-based analysis
- (2017) Patrick O. Richard et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Statin use and endometrial cancer risk: a meta-analysis
- (2017) Jing Yang et al. Oncotarget
- Impact of Statin Use on Outcomes in Triple Negative Breast Cancer
- (2017) Simona F. Shaitelman et al. Journal of Cancer
- Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study
- (2016) Emmanuel Bachy et al. AMERICAN JOURNAL OF HEMATOLOGY
- Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer
- (2016) Claire Hardie et al. Asia-Pacific Journal of Clinical Oncology
- Statin Use and Survival with Early-Stage Hepatocellular Carcinoma
- (2016) C. Y. Jeon et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Statin Use and Prostate Cancer Aggressiveness: Results from the Population-Based North Carolina-Louisiana Prostate Cancer Project
- (2016) E. H. Allott et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Combined inhibition of the mevalonate pathway with statins and zoledronic acid potentiates their anti-tumor effects in human breast cancer cells
- (2016) Andy Göbel et al. CANCER LETTERS
- Long-Term Effectiveness and Safety of Pravastatin in Patients With Coronary Heart DiseaseCLINICAL PERSPECTIVE
- (2016) Wendy E. Hague et al. CIRCULATION
- Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin TherapyCLINICAL PERSPECTIVE
- (2016) Ian Ford et al. CIRCULATION
- Statins and survival outcomes in patients with metastatic renal cell carcinoma
- (2016) Rana R. McKay et al. EUROPEAN JOURNAL OF CANCER
- A phase I study of high-dose rosuvastatin with standard dose erlotinib in patients with advanced solid malignancies
- (2016) Glenwood D. Goss et al. Journal of Translational Medicine
- The effect of statins on survival in patients with stage IV lung cancer
- (2016) Jenny J. Lin et al. LUNG CANCER
- Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
- (2016) Do Chang Moon et al. YONSEI MEDICAL JOURNAL
- Long-term statin use in patients with lung cancer and dyslipidemia reduces the risk of death
- (2016) Wen-Yen Huang et al. Oncotarget
- Disentangling the Association between Statins, Cholesterol, and Colorectal Cancer: A Nested Case-Control Study
- (2016) Ronac Mamtani et al. PLOS MEDICINE
- Blood lipids and prostate cancer: a Mendelian randomization analysis
- (2016) Caroline J. Bull et al. Cancer Medicine
- Impact of Statin Use on Survival in Patients Undergoing Resection for Early-Stage Pancreatic Cancer
- (2015) Bechien U Wu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection
- (2015) Antonio Luigi Pastore et al. BMC CANCER
- A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
- (2015) S H Lim et al. BRITISH JOURNAL OF CANCER
- Statin use and survival in elderly patients with endometrial cancer
- (2015) Lara S. Yoon et al. GYNECOLOGIC ONCOLOGY
- Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis
- (2015) Haixia Sun et al. Lipids in Health and Disease
- The Prognostic Effect of Statin Use on Urologic Cancers
- (2015) You Luo et al. MEDICINE
- Association Between Statin Use and Endometrial Cancer Survival
- (2015) Nicole S. Nevadunsky et al. OBSTETRICS AND GYNECOLOGY
- Statin use and risk of disease recurrence and death after radical prostatectomy
- (2015) Teemu Keskiväli et al. PROSTATE
- Statin use and risk of bladder cancer: a meta-analysis
- (2013) Xiao-long Zhang et al. CANCER CAUSES & CONTROL
- Use of Statins and the Risk of Death in Patients With Prostate Cancer
- (2013) Oriana Yu et al. JOURNAL OF CLINICAL ONCOLOGY
- Statins and the Risk of Lung Cancer: A Meta-Analysis
- (2013) Min Tan et al. PLoS One
- Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies
- (2012) Linda J. Wedlake et al. EUROPEAN JOURNAL OF CANCER
- Prenyltransferases Regulate CD20 Protein Levels and Influence Anti-CD20 Monoclonal Antibody-mediated Activation of Complement-dependent Cytotoxicity
- (2012) Magdalena Winiarska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Statin Use and Reduced Cancer-Related Mortality
- (2012) Sune F. Nielsen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity
- (2010) J. Bil et al. BLOOD
- Statins and Breast Cancer: May Matrix Metalloproteinase be the Missing Link
- (2009) Ferdinando Mannello et al. CANCER INVESTIGATION
- Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro
- (2009) Jacek Bil et al. CANCER LETTERS
- Targeting the Mevalonate Pathway for Improved Anticancer Therapy
- (2009) G. Fritz CURRENT CANCER DRUG TARGETS
- Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
- (2008) Magdalena Winiarska et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search